Quest Diagnostics Continues To Post Steep Loss In Late-Day Trading

(RTTNews) - Shares of Quest Diagnostics Inc. (DGX) continue to see substantial weakness in late-day trading on Thursday after falling sharply early in the session. After hitting a two-year intraday low, Quest Diagnostics is currently down by 9.2 percent.

Quest Diagnostics initially came under pressure after the lab testing services provider lowered its full-year earnings and revenue forecast.

The company said it now expects full-year earnings greater than $6.30 per share on revenues of approximately $7.57 billion compared to its previous forecast for earnings of $6.53 to $6.60 per share on revenues of around $7.62 billion.